B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL).
作者信息
Petersen D L, Krejsgaard T, Berthelsen J, Fredholm S, Willerslev-Olsen A, Sibbesen N A, Bonefeld C M, Andersen M H, Francavilla C, Olsen J V, Hu T, Zhang M, Wasik M A, Geisler C, Woetmann A, Odum N
机构信息
Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Center for Cancer Immune Therapy (CCIT), Department of Hematology, Herlev University Hospital, Herlev, Denmark.
出版信息
Leukemia. 2014 Oct;28(10):2109-12. doi: 10.1038/leu.2014.192. Epub 2014 Jun 12.
Abstract
摘要
Zotero 插件